• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过使用与蛋白质结合的反义寡核苷酸对可变前体信使核糖核酸剪接进行重编程。

Reprogramming alternative pre-messenger RNA splicing through the use of protein-binding antisense oligonucleotides.

作者信息

Villemaire Jonathan, Dion Isabelle, Elela Sherif Abou, Chabot Benoit

机构信息

Département de microbiologie et d'infectiologie, RNA/RNP Group, Faculté de Médecine, Université de Sherbrooke, Sherbrooke, Québec J1H 5N4, Canada.

出版信息

J Biol Chem. 2003 Dec 12;278(50):50031-9. doi: 10.1074/jbc.M308897200. Epub 2003 Sep 30.

DOI:10.1074/jbc.M308897200
PMID:14522969
Abstract

Alternative pre-messenger RNA splicing is a major contributor to proteomic diversity in higher eukaryotes and represents a key step in the control of protein function in a large variety of biological systems. As a means of artificially altering splice site choice, we have investigated the impact of positioning proteins in the vicinity of 5' splice sites. We find that a recombinant GST-MS2 protein interferes with 5' splice site use, most efficiently when it binds upstream of that site. To broaden the use of proteins as steric inhibitors of splicing, we have tested the activity of antisense oligonucleotides carrying binding sites for the heterogeneous nuclear ribonucleoprotein A1/A2 proteins. In a HeLa cell extract, tailed oligonucleotides complementary to exonic sequences elicit strong shifts in 5' splice site selection. In four different human cell lines, an interfering oligonucleotide carrying A1/A2 binding sites also shifted the alternative splicing of the Bcl-x pre-mRNA more efficiently than oligonucleotides acting through duplex formation only. The use of protein-binding oligonucleotides that interfere with U1 small nuclear ribonucleoprotein binding therefore represents a novel and powerful approach to control splice site selection in cells.

摘要

可变前体信使核糖核酸剪接是高等真核生物蛋白质组多样性的主要贡献因素,并且是多种生物系统中蛋白质功能调控的关键步骤。作为一种人为改变剪接位点选择的方法,我们研究了将蛋白质定位在5'剪接位点附近的影响。我们发现重组GST-MS2蛋白会干扰5'剪接位点的使用,当它结合在该位点上游时效率最高。为了拓宽蛋白质作为剪接空间抑制剂的应用,我们测试了携带异质核核糖核蛋白A1/A2蛋白结合位点的反义寡核苷酸的活性。在HeLa细胞提取物中,与外显子序列互补的带尾寡核苷酸会引起5'剪接位点选择的强烈变化。在四种不同的人类细胞系中,携带A1/A2结合位点的干扰性寡核苷酸也比仅通过双链形成起作用的寡核苷酸更有效地改变了Bcl-x前体信使核糖核酸的可变剪接。因此,使用干扰U1小核核糖核蛋白结合的蛋白质结合寡核苷酸是一种在细胞中控制剪接位点选择的新颖且强大的方法。

相似文献

1
Reprogramming alternative pre-messenger RNA splicing through the use of protein-binding antisense oligonucleotides.通过使用与蛋白质结合的反义寡核苷酸对可变前体信使核糖核酸剪接进行重编程。
J Biol Chem. 2003 Dec 12;278(50):50031-9. doi: 10.1074/jbc.M308897200. Epub 2003 Sep 30.
2
The RNA-binding protein TIA-1 is a novel mammalian splicing regulator acting through intron sequences adjacent to a 5' splice site.RNA 结合蛋白 TIA-1 是一种新型的哺乳动物剪接调节因子,它通过与 5' 剪接位点相邻的内含子序列发挥作用。
Mol Cell Biol. 2000 Sep;20(17):6287-99. doi: 10.1128/MCB.20.17.6287-6299.2000.
3
The U1 snRNP base pairs with the 5' splice site within a penta-snRNP complex.U1 小核核糖核蛋白颗粒在一个五重小核核糖核蛋白颗粒复合物中与 5' 剪接位点形成碱基对。
Mol Cell Biol. 2003 May;23(10):3442-55. doi: 10.1128/MCB.23.10.3442-3455.2003.
4
The splicing regulator TIA-1 interacts with U1-C to promote U1 snRNP recruitment to 5' splice sites.剪接调节因子TIA-1与U1-C相互作用,促进U1 snRNP募集到5'剪接位点。
EMBO J. 2002 Dec 16;21(24):6882-92. doi: 10.1093/emboj/cdf668.
5
Redirecting splicing with bifunctional oligonucleotides.用双功能寡核苷酸重定向剪接
Nucleic Acids Res. 2014 Apr;42(6):e40. doi: 10.1093/nar/gkt1287. Epub 2013 Dec 26.
6
Pathways for selection of 5' splice sites by U1 snRNPs and SF2/ASF.U1 小核核糖核蛋白颗粒(snRNPs)和 SF2/ASF 选择 5' 剪接位点的途径。
EMBO J. 1993 Sep;12(9):3607-17. doi: 10.1002/j.1460-2075.1993.tb06034.x.
7
Heterogeneous nuclear ribonucleoprotein F/H proteins modulate the alternative splicing of the apoptotic mediator Bcl-x.不均一核核糖核蛋白F/H可调节凋亡介质Bcl-x的可变剪接。
J Biol Chem. 2005 Jun 17;280(24):22641-50. doi: 10.1074/jbc.M501070200. Epub 2005 Apr 18.
8
Modulation of 5' splice site selection using tailed oligonucleotides carrying splicing signals.使用携带剪接信号的带尾寡核苷酸对5'剪接位点选择进行调控。
BMC Biotechnol. 2006 Jan 13;6:5. doi: 10.1186/1472-6750-6-5.
9
Antagonistic effects of the SRp30c protein and cryptic 5' splice sites on the alternative splicing of the apoptotic regulator Bcl-x.SRp30c蛋白与隐蔽性5'剪接位点对凋亡调节因子Bcl-x可变剪接的拮抗作用
J Biol Chem. 2008 Aug 1;283(31):21315-24. doi: 10.1074/jbc.M800353200. Epub 2008 Jun 5.
10
hnRNP A1 controls HIV-1 mRNA splicing through cooperative binding to intron and exon splicing silencers in the context of a conserved secondary structure.异质性核糖核蛋白A1通过在保守二级结构背景下与内含子和外显子剪接沉默子协同结合来控制HIV-1 mRNA剪接。
RNA. 2002 Nov;8(11):1401-15. doi: 10.1017/s1355838202023075.

引用本文的文献

1
Cas13d-mediated isoform-specific RNA knockdown with a unified computational and experimental toolbox.利用统一的计算和实验工具箱实现Cas13d介导的异构体特异性RNA敲低。
Nat Commun. 2025 Jul 29;16(1):6948. doi: 10.1038/s41467-025-62066-5.
2
Strategies for programmable manipulation of alternative splicing.可编程剪接的策略。
Curr Opin Genet Dev. 2024 Dec;89:102272. doi: 10.1016/j.gde.2024.102272. Epub 2024 Oct 29.
3
From computational models of the splicing code to regulatory mechanisms and therapeutic implications.从剪接密码的计算模型到调控机制及治疗意义
Nat Rev Genet. 2025 Mar;26(3):171-190. doi: 10.1038/s41576-024-00774-2. Epub 2024 Oct 2.
4
Optimization of Bifunctional Antisense Oligonucleotides for Regulation of Mutually Exclusive Alternative Splicing of Gene.基因互斥性选择性剪接的双功能反义寡核苷酸的优化。
Molecules. 2022 Sep 3;27(17):5682. doi: 10.3390/molecules27175682.
5
Therapeutic Modulation of RNA Splicing in Malignant and Non-Malignant Disease.治疗性调控 RNA 剪接在恶性和非恶性疾病中的作用。
Trends Mol Med. 2021 Jul;27(7):643-659. doi: 10.1016/j.molmed.2021.04.005. Epub 2021 May 13.
6
Innovative Therapeutic and Delivery Approaches Using Nanotechnology to Correct Splicing Defects Underlying Disease.利用纳米技术纠正疾病潜在剪接缺陷的创新治疗与递送方法。
Front Genet. 2020 Jul 14;11:731. doi: 10.3389/fgene.2020.00731. eCollection 2020.
7
Alternative Splicing as a Target for Cancer Treatment.选择性剪接作为癌症治疗的靶点。
Int J Mol Sci. 2018 Feb 11;19(2):545. doi: 10.3390/ijms19020545.
8
Targeting Splicing in the Treatment of Human Disease.靶向剪接在人类疾病治疗中的应用
Genes (Basel). 2017 Feb 24;8(3):87. doi: 10.3390/genes8030087.
9
New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies.新型CD20可变剪接变体:血液学B细胞恶性肿瘤中的分子鉴定与差异表达
Exp Hematol Oncol. 2016 Mar 1;5:7. doi: 10.1186/s40164-016-0036-3. eCollection 2015.
10
The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression.剪接因子 RBM4 控制细胞凋亡、增殖和迁移,从而抑制肿瘤进展。
Cancer Cell. 2014 Sep 8;26(3):374-389. doi: 10.1016/j.ccr.2014.07.010.